Caprock Group’s Strata Critical Medical Inc SRTA Stock Holding History

Caprock Group’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177K	Buy	+33,664	New	+$177K	﹤0.01%	1180
2026 Q1	–	Sell	-70,815	Closed	-$341K	–	1135
2025 Q4	$341K	Buy	70,815 +32,783	+86%	+$159K	0.01%	952
2025 Q3	$166K	Buy	+38,032	New	+$168K	﹤0.01%	1080
2025 Q1	$84.6K	Hold	31,000	–	–	﹤0.01%	1040
2024 Q4	$132K	Hold	31,000	–	–	﹤0.01%	959
2024 Q3	$91.1K	Hold	31,000	–	–	﹤0.01%	874
2024 Q2	$108K	Hold	31,000	–	–	﹤0.01%	824
2024 Q1	$88.3K	Hold	31,000	–	–	0.01%	702
2023 Q4	$109K	Buy	+31,000	New	+$89K	0.01%	673

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caprock Group's SRTA Position: Q2 2026 in Review

Caprock Group opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 33,664 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #1180 among its holdings. This is a return to the name: Caprock Group previously reported a position in SRTA as recently as Q4 2025.

Caprock Group first reported a position in SRTA in Q4 2023 and has held it in 9 quarters since. The position peaked at $341K in Q4 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Caprock Group held 33,664 shares of Strata Critical Medical Inc worth $177K as of Q2 2026.
Strata Critical Medical Inc was a new Caprock Group position in Q2 2026.
Strata Critical Medical Inc made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1180 holding.
Caprock Group first reported a position in Strata Critical Medical Inc in Q4 2023 and has held it in 9 quarters since.
Caprock Group's Strata Critical Medical Inc position peaked at $341K in Q4 2025.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.